Vill K, Muller-Felber W, Landfarth T, Koppl C, Herzig N, Knerr C, Holla H, Steidle G, Harms E, Hohenfellner K, Interdisciplinary Cystinosis Group (2022) Neuromuscular conditions and the impact of cystine-depleting therapy in infantile nephropathic cystinosis: a cross-sectional analysis of 55 patients
However, most users start noticing smoother joint movement, reduced chronic inflammation, and visible improvements in muscle recovery or soft tissue repair within 23 weeks
Sndrome de Adams-Stokes: Esta condicin, caracterizada por episodios de sncope y bradicardia, contraindica el uso de Eptona debido al riesgo de exacerbar problemas cardiovasculares
A single temperature excursion above 8C for more than 2 hours can trigger irreversible oxidative degradation of B12 and lipotropic amino acids